Arndt Vogel
@arndtvogel
Clinician-scientist, focused on liver cancer & precision oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪
ID: 1211086357
23-02-2013 08:40:33
1,1K Tweet
6,6K Takipçi
440 Takip Edilen
Trastuzumab deruxtecan in HER2+ gastric cancer Nature Medicine doi.org/10.1038/s41591… 🔎exploratory biomarker analysis of DESTINY Gastric01 👉64% concordance btw HER2+ IHC & 🩸 👉MET, EGFR & FGFR2 GA: ORR⬇️ 👉HER2 mutations: ORR⬆️ 👉activity in Her2 low ESMO - Eur. Oncology